Abiopharma

First Financial Completes Conversion of BankFinancial

CHARTER NAMES CHRIS HACKER HEAD OF CORPORATE SECURITY

Clinical trial NCT06185764 updates: 1. completion date: 2026-12-22 → 2027-02-02 2. primary completion date: 2026-12-22 → 2027-02-02 3. enrollment: 44 → 52 participants

Clinical trial NCT07041775 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-01 → 2026-06-04

Clinical trial NCT06430671 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2025-12-01 → 2025-12-23 3. primary completion date: 2025-12-01 → 2025-12-23

Clinical trial NCT04176718 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 43 → 44 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07489066 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-04-01 → 2026-06-01 3. completion date: 2031-08-05 → 2031-07-30 4. primary completion date: 2028-08-04 → 2028-07-29

Clinical trial NCT05789069 updates: 1. completion date: 2025-12-01 → 2026-12-01 2. primary completion date: 2025-12-01 → 2026-12-01

Clinical trial NCT04811560: primary completion date: 2026-06-30 → 2027-02-26.

Clinical trial NCT04871282 updates: 1. start date: 2021-03-30 → 2021-09-01 2. completion date: 2026-10-01 → 2026-12-01 3. masking: TRIPLE → QUADRUPLE